80 related articles for article (PubMed ID: 10575224)
1. Refined physical mapping and genomic structure of the EXTL1 gene.
Wuyts W; Spieker N; Van Roy N; De Boulle K; De Paepe A; Willems PJ; Van Hul W; Versteeg R; Speleman F
Cytogenet Cell Genet; 1999; 86(3-4):267-70. PubMed ID: 10575224
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
[TBL] [Abstract][Full Text] [Related]
3. Assignment of the mouse Extl1 gene to the distal part of chromosome 4 by in situ hybridization and radiation hybrid mapping.
Mathysen D; Wuyts W; Bossuyt PJ; Wauters JG; Van Hul W
Cytogenet Cell Genet; 2001; 92(1-2):162-3. PubMed ID: 11306818
[No Abstract] [Full Text] [Related]
4. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R
Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802
[TBL] [Abstract][Full Text] [Related]
5. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
[TBL] [Abstract][Full Text] [Related]
7. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.
Katoh M; Katoh M
Int J Oncol; 2003 Oct; 23(4):1219-24. PubMed ID: 12964007
[TBL] [Abstract][Full Text] [Related]
9. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
10. Characterization and genomic localization of the mouse Extl2 gene.
Wuyts W; Van Hul W
Cytogenet Cell Genet; 2000; 89(3-4):185-8. PubMed ID: 10965119
[TBL] [Abstract][Full Text] [Related]
11. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.
Kim BT; Kitagawa H; Tamura J; Saito T; Kusche-Gullberg M; Lindahl U; Sugahara K
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7176-81. PubMed ID: 11390981
[TBL] [Abstract][Full Text] [Related]
12. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
13. Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene.
Judson H; van Roy N; Strain L; Vandesompele J; Van Gele M; Speleman F; Bonthron DT
Hum Genet; 2000 Apr; 106(4):406-13. PubMed ID: 10830907
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.
Ejeskär K; Abel F; Sjöberg R; Bäckström J; Kogner P; Martinsson T
Cytogenet Cell Genet; 2000; 89(1-2):62-6. PubMed ID: 10894940
[TBL] [Abstract][Full Text] [Related]
15. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
17. Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells.
Barker PE; Savelyeva L; Schwab M
Oncogene; 1993 Dec; 8(12):3353-8. PubMed ID: 8247537
[TBL] [Abstract][Full Text] [Related]
18. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
19. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
[TBL] [Abstract][Full Text] [Related]
20. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
